HK Stock Market Move | Jiangsu Lopal Tech. Group (02465) rose more than 3%. It is reported that leading companies in the industry are preparing to adjust prices. The company is optimistic about the future price trend of lithium iron phosphate.
Longpan Technology (02465) rose more than 3%, as of the time of publication, it increased by 3.15% to HK$14.74, with a transaction volume of HK$84,349,700.
Jiangsu Lopal Tech. Group (02465) rose more than 3%, as of the publication, up by 3.15% to 14.74 Hong Kong dollars, with a turnover of 84.34 million Hong Kong dollars.
On the news front, according to market media reports, several leading lithium iron phosphate companies have proposed price increases. Two top lithium iron phosphate manufacturers plan to raise processing fees for their entire range of products by 3000 yuan/ton starting from 2026, attracting market attention. Jiangsu Lopal Tech. Group stated on the investor interaction platform that there is indeed a trend of price increases in the industry recently, and the company's sales staff are actively communicating with customers about the reasons for the price hikes. The staff member stated that with the rise in raw material prices for lithium iron phosphate and the pressure on profit margins in the industry, coupled with continued expansion in market demand, price increases are an inevitable trend in the industry, and the company is optimistic about the future price trends for lithium iron phosphate.
An analyst from Sublime China Information stated that 2025 will be a key turning point year for the development of the lithium iron phosphate industry, as explosive growth in demand contrasts sharply with structural contradictions on the supply side, resulting in a special pattern of high growth and low profitability in the industry. With the implementation of the "anti-internal competition" initiative, accelerated technological upgrades, and improvements in the supply-demand structure, the lithium iron phosphate industry will gradually move away from vicious competition, entering a new stage focused on technology and value, with positive changes in prices, supply and demand, and industry prospects.
Related Articles

HK Stock Market Move | HUA MEDICINE-B(02552) rose over 3% as the second-generation GKA American MAD Ib trial succeeded in dosing. The company plans to seek future cooperation partners.

Zhongtai: The trend of market-oriented electricity production is clear, and the demand for photovoltaics is entering the observation window.

A-share midday review | Market index fluctuates weakly Hainan local stocks fluctuate rebound Precious metal sector rises
HK Stock Market Move | HUA MEDICINE-B(02552) rose over 3% as the second-generation GKA American MAD Ib trial succeeded in dosing. The company plans to seek future cooperation partners.

Zhongtai: The trend of market-oriented electricity production is clear, and the demand for photovoltaics is entering the observation window.

A-share midday review | Market index fluctuates weakly Hainan local stocks fluctuate rebound Precious metal sector rises

RECOMMEND

Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025

Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025

As The 2025 Central Economic Work Conference Approaches, What New Expectations Lie Ahead For Next Year’s Economic Agenda? Institutions Forecast Five Key Highlights
08/12/2025


